216 related articles for article (PubMed ID: 21518552)
41. Pancreas transplantation in the United States as reported to the United Network for Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry.
Sutherland DE; Gruessner A
Clin Transpl; 1995; ():49-67. PubMed ID: 8794254
[TBL] [Abstract][Full Text] [Related]
42. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653
[TBL] [Abstract][Full Text] [Related]
43. Early rejection: analyses of the UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1990; ():577-84. PubMed ID: 2103174
[TBL] [Abstract][Full Text] [Related]
44. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
[TBL] [Abstract][Full Text] [Related]
45. Clinical aspects of sensitization.
Katznelson S; Bhaduri S; Cecka JM
Clin Transpl; 1997; ():285-96. PubMed ID: 9919412
[TBL] [Abstract][Full Text] [Related]
46. Analysis of United States (US) and non-US pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS).
Gruessner AC; Sutherland DE
Clin Transpl; 1998; ():53-73. PubMed ID: 10503085
[TBL] [Abstract][Full Text] [Related]
47. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
48. Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.
Augustine JJ; Woodside KJ; Padiyar A; Sanchez EQ; Hricik DE; Schulak JA
Transplantation; 2012 Oct; 94(7):738-43. PubMed ID: 22955228
[TBL] [Abstract][Full Text] [Related]
49. Algorithm to manage highly sensitized kidney transplant recipients in Poland.
Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P
Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185
[TBL] [Abstract][Full Text] [Related]
50. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
[TBL] [Abstract][Full Text] [Related]
51. Rituximab in highly sensitized kidney transplant recipients.
Munoz AS; Rioveros AA; Cabanayan-Casasola CB; Danguilan RA; Ona ET
Transplant Proc; 2008 Sep; 40(7):2218-21. PubMed ID: 18790197
[TBL] [Abstract][Full Text] [Related]
52. Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine.
Cai J; Wu G; Qing A; Everly M; Cheng E; Terasaki P
Clin Transpl; 2014; ():33-47. PubMed ID: 26281125
[TBL] [Abstract][Full Text] [Related]
53. [Calculated panel reactive antibody method for assessing the probability of kidney recipients to receive transplantation].
Luo M; Yu L; Xiao L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):477-81. PubMed ID: 24752091
[TBL] [Abstract][Full Text] [Related]
54. The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients.
Redfield RR; Scalea JR; Zens TJ; Mandelbrot DA; Leverson G; Kaufman DB; Djamali A
Nephrol Dial Transplant; 2016 Oct; 31(10):1746-53. PubMed ID: 27387475
[TBL] [Abstract][Full Text] [Related]
55. Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.
Morris AA; Cole RT; Veledar E; Bellam N; Laskar SR; Smith AL; Gebel HM; Bray RA; Butler J
J Am Coll Cardiol; 2013 Dec; 62(24):2308-15. PubMed ID: 23994416
[TBL] [Abstract][Full Text] [Related]
56. The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients.
Kolonko A; Bzoma B; Giza P; Styrc B; Sobolewski M; Chudek J; Dębska-Ślizień A; Więcek A
Medicina (Kaunas); 2018 Sep; 54(5):. PubMed ID: 30344297
[No Abstract] [Full Text] [Related]
57. Expression characteristics of major histocompatibility complex class I-related chain A antibodies and immunoadsorption effect in sensitized recipients of kidney transplantation.
Yao QC; Wang W; Li XB; Yin H; Zhang XD
Chin Med J (Engl); 2011 Mar; 124(5):669-73. PubMed ID: 21518555
[TBL] [Abstract][Full Text] [Related]
58. Transplant nephrectomy after allograft failure is associated with allosensitization.
Knight MG; Tiong HY; Li J; Pidwell D; Goldfarb D
Urology; 2011 Aug; 78(2):314-8. PubMed ID: 21676445
[TBL] [Abstract][Full Text] [Related]
59. B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients.
Mahoney RJ; Taranto S; Edwards E
Hum Immunol; 2002 Apr; 63(4):324-35. PubMed ID: 12039415
[TBL] [Abstract][Full Text] [Related]
60. Probability of deceased donor kidney transplantation based on % PRA.
Bostock IC; Alberú J; Arvizu A; Hernández-Mendez EA; De-Santiago A; González-Tableros N; López M; Castelán N; Contreras AG; Morales-Buenrostro LE; Gabilondo B; Vilatobá M
Transpl Immunol; 2013 Jun; 28(4):154-8. PubMed ID: 23684945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
